Journal of Analytical & Bioanalytical Techniques
Open Access

Transcriptome; Microarray technology; Gene expression; RNA profiling; Biomarkers

Method

Sample collection and RNA extraction:

• Obtain biological samples (e.g., tissues, cells, or body fluids) of interest.

• Isolate total RNA using techniques like TRIzol extraction or commercial RNA isolation kits.

• Assess RNA quality and quantity using spectrophotometry or electrophoresis.

RNA labeling:

• Amplify and label the RNA samples, often using reverse transcription to generate complementary DNA (cDNA).

• Introduce fluorescent dyes (e.g., Cy3 and Cy5) during the labeling process to enable later detection.

Microarray probe design and fabrication:

• Design microarray probes or oligonucleotide sequences that correspond to specific genes or transcripts of interest.

• Synthesize or spot these probes onto the microarray chip, typically arranged in a grid.

Hybridization:

• Incubate the labeled cDNA or RNA samples with the microarray.

• Allow complementary binding of the labeled targets to the immobilized probes.

• Hybridization conditions, such as temperature and salt concentration, are optimized for specific microarray platforms [1-4].

Washing and scanning:

• Wash away unbound or non-specifically bound cDNA or RNA.

• Scan the microarray to measure the fluorescence signals from the bound targets.

• Dual-channel microarrays use different fluorophores for two conditions (e.g., control and experimental samples) to enable direct comparisons.

Data acquisition and preprocessing:

• Capture and store images of the microarray spots.

• Extract and Preprocess raw fluorescence intensity data, including background correction and normalization.

Statistical analysis:

• Conduct statistical analysis to identify differentially expressed genes between conditions or groups.

• Apply statistical tests, such as t-tests, ANOVA, or foldchange cutoffs to determine significance.

Functional annotation and pathway analysis:

• Annotate identified genes using databases like Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG).

• Perform pathway analysis to uncover biological pathways enriched in the differentially expressed genes.

Validation:

• Validate microarray findings using quantitative real-time PCR (qPCR) or other independent methods.

Data visualization and interpretation:

• Visualize results using heatmaps, volcano plots, or other graphical representations.

• Interpret the biological relevance of the identified gene expression changes and regulatory networks.

Integration with additional data: Integrate microarray data with other omics data (e.g., proteomics, metabolomics) for a comprehensive understanding of biological processes.

Reporting and publication: Present findings in research articles, reports, or presentations to share discoveries with the scientific community.

The methods outlined above provide a structured approach for leveraging microarray technology to explore the transcriptome comprehensively. While alternative technologies like RNA sequencing (RNA-Seq) have gained popularity, microarrays remain a valuable and cost-effective option for transcriptome analysis, especially for largescale studies and when working with well-annotated genomes [5-8].

Discussion

Transcriptome exploration with microarray technology: Microarray technology has been pivotal in deciphering the transcriptome by allowing researchers to simultaneously assess the expression levels of thousands of genes in a single experiment. This high-throughput capability has revolutionized our understanding of gene expression patterns and regulation.

Applications of microarray-based transcriptomics

Gene expression profiling: Microarrays have been extensively used for gene expression profiling, enabling the identification of differentially expressed genes in various biological contexts. This has led to insights into disease mechanisms, developmental processes, and responses to external stimuli.

Alternative splicing analysis: Microarrays can uncover alternative splicing events, shedding light on the diversity of transcripts generated from a single gene, which is crucial for functional diversity.

Non-coding RNA discovery: Microarrays have been instrumental in identifying and characterizing non-coding RNAs, such as microRNAs and long non-coding RNAs, which play essential roles in gene regulation.

Time-course experiments: Researchers use microarrays to capture dynamic changes in gene expression over time, providing valuable insights into biological processes and responses to treatments.

Advantages of microarrays:

Cost-effective: Microarrays remain cost-effective for large-scale transcriptome studies, making them accessible to a broad range of researchers.

Accessibility to well-annotated genomes: Microarrays are particularly suitable for species with well-annotated genomes, where probe design is more straightforward.

Complementary to other technologies: While RNA sequencing (RNA-Seq) has gained popularity for transcriptomics, microarrays still offer valuable complementary information, especially for validation and targeted studies [9,10].

Limitations and challenges

Limited dynamic range: Microarrays may have a limited dynamic range compared to RNA-Seq, potentially leading to saturation effects in highly expressed genes and reduced sensitivity for low-expression genes.

Probe design biases: Microarray results can be influenced by probe design biases, affecting the accuracy of quantification.

Inability to Detect Novel Transcripts: Unlike RNA-Seq, microarrays cannot discover novel transcripts or splice variants.

Future prospects: Microarray technology continues to evolve. Advances in probe design, data analysis methodologies, and integration with other omics data sources are expected to enhance accuracy and reliability.

Integration with single-cell technologies: Combining microarrays with emerging single-cell RNA sequencing techniques offers exciting prospects for understanding cell-specific gene expression patterns within heterogeneous tissues.

Clinical applications: Microarrays hold promise for personalized medicine, with the potential to identify patient-specific gene expression profiles for disease diagnosis, prognosis, and treatment decisions.

Conclusion

Microarray technology has significantly contributed to our understanding of the transcriptome, offering a cost-effective and accessible means to explore gene expression patterns. While RNA-Seq has expanded the possibilities in transcriptomics, microarrays remain relevant and continue to evolve, ensuring their continued role in unraveling the complex world of gene expression. Researchers should carefully consider the specific research goals and the advantages and limitations of each technology when choosing between microarrays and RNA-Seq for transcriptome analysis.

Acknowledgement

None

1. Jomezadeh N, Babamoradi S, Kalantar E, Javaherizadeh H (2014) Isolation and antibiotic susceptibility of Shigella species from stool samplesamong hospitalized children in Abadan, Iran. Gastroenterol Hepatol Bed Bench 7: 218.

Google Scholar, Indexed at

2. Sangeetha A, Parija SC, Mandal J, Krishnamurthy S (2014) Clinical and microbiological profiles of shigellosis in children. J Health Popul Nutr 32: 580.

Google Scholar, Indexed at

3. Ranjbar R, Dallal MMS, Talebi M, Pourshafie MR (2008) Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran. J Health Popul Nutr 26: 426.

Google Scholar, Crossref, Indexed at

4. Zhang J, Jin H, Hu J, Yuan Z, Shi W, Yang X, et al. (2014) Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004–2011. Diagn Microbiol Infect Dis 78: 282–286.

Google Scholar, Crossref, Indexed at

5. Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, Afsharpaiman S, et al. (2010) Frequency and antimicrobial susceptibility of Shigella species isolated in children medical center hospital, Tehran, Iran, 2001–2006. Braz J Infect Dis 14: 153–157.

Google Scholar, Crossref, Indexed at

6. Von-Seidlein L, Kim DR, Ali M, Lee HH, Wang X, Thiem VD, et al. (2006) A multicentre study of Shigella diarrhoea in six Asian countries: Disease burden, clinical manifestations, and microbiology. PLoS Med 3: e353.

Google Scholar, Crossref, Indexed at

7. Germani Y, Sansonetti PJ (2006) The genus Shigella. The prokaryotes In: Proteobacteria: Gamma Subclass Berlin: Springer 6: 99-122.

Google Scholar

8. Aggarwal P, Uppal B, Ghosh R, Krishna Prakash S, Chakravarti A, et al. (2016) Multi drug resistance and extended spectrum beta lactamases in clinical isolates of Shigella: a study from New Delhi, India. Travel Med Infect Dis 14: 407–413.

Google Scholar, Crossref, Indexed at

9. Taneja N, Mewara A (2016) Shigellosis: epidemiology in India. Indian J Med Res 143: 565-576.

Google Scholar, Crossref, Indexed at

10. Farshad S, Sheikhi R, Japoni A, Basiri E, Alborzi A (2006) Characterizationof Shigella strains in Iran by plasmid profile analysis and PCR amplification of ipa genes. J Clin Microbiol 44: 2879–2883.

Google Scholar, Crossref, Indexed at